ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reddel, H.
Right arrow Articles by Woolcock, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reddel, H.
Right arrow Articles by Woolcock, A.
Eur Respir J 1998; 12: 309-314
Copyright © ERS Journals Ltd 1998

Clinical Trial

Standardization of ambulatory peak flow monitoring: the importance of recent beta2-agonist inhalation

HK Reddel, SI Ware, CM Salome, GB Marks, CR Jenkins, and AJ Woolcock

Standardization of conditions for peak expiratory flow (PEF) monitoring is much more difficult in practice than for laboratory spirometry. Patients are usually asked to record PEF before medication. The aim of this study was to determine the effect of prior bronchodilator use on PEF outcome measures in a clinical trial. Electronic PEF records from 43 subjects with poorly controlled asthma were examined to determine the frequency with which beta2-agonist was inhaled <4 h before PEF measurement, as such PEF are potentially "postbronchodilator". The effect of inclusion of such PEF values on improvement in PEF outcome measures after 8 weeks of inhaled budesonide was calculated. Subjects were asked to record PEF before medication. During run-in, the median frequency of postbronchodilator PEF was 29%, falling to 0% after 8 weeks of budesonide. Inclusion of postbronchodilator PEF led to an overestimation of average morning, evening and daily PEF during run-in (p<0.001). Improvement in these indices with treatment was, therefore, underestimated. Minimum morning PEF expressed as per cent personal best was unaffected. Subjects may not be able to withhold beta2-agonist for 4 h before every peak flow reading. This may change as the level of asthma control changes, leading to a systematic bias in clinical trial end-points or inaccuracy in individual treatment decisions. Simple changes to peak expiratory flow instructions and analysis are proposed.


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice
Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 59 - 99.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. F. J. Brouwer, R. J. Roorda, and P. L. P. Brand
Home spirometry and asthma severity in children
Eur. Respir. J., December 1, 2006; 28(6): 1131 - 1137.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. F. Goldstein, B. A. Veza, E. H. Dunsky, D. J. Dvorin, G. A. Belecanech, and I. C. Haralabatos
Comparisons of Peak Diurnal Expiratory Flow Variation, Postbronchodilator FEV1 Responses, and Methacholine Inhalation Challenges in the Evaluation of Suspected Asthma
Chest, April 1, 2001; 119(4): 1001 - 1010.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. ALMQVIST, M. WICKMAN, L. PERFETTI, N. BERGLIND, A. RENSTROM, M. HEDREN, K. LARSSON, G. HEDLIN, and P. MALMBERG
Worsening of Asthma in Children Allergic to Cats, after Indirect Exposure to Cat at School
Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 694 - 698.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
H. Reddel, C. Jenkins, and A. Woolcock
Diurnal variability---time to change asthma guidelines?
BMJ, July 3, 1999; 319(7201): 45 - 47.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the European Respiratory Society.